近期论文

查看导师新发文章 （温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Abuhelwa, AY, Mudge, S, Hayes, D, Upton, RN & Foster, DJ 2016, 'Population In Vitro-In Vivo correlation model linking gastrointestinal transit time, pH, and pharmacokinetics: itraconazole as a model drug', Pharmaceutical Research, v. 33, no. 7, pp. 1782-1794. Bazargan, M, Foster, DJR, Muhlhausler, BS, Morrison, JL, McMillen, I & Davey, AK 2016, 'Limited fetal metabolism of rosiglitazone: elimination via the maternal compartment in the pregnant ewe', Reproductive Toxicology, v. 61, pp. 162-168. Kn?sgaard, KR, Foster, DJR, Kreilgaard, M, Sverrisdóttir, E, Upton, RN & van den Anker, JN 2016, 'Pharmacokinetic models of morphine and its metabolites in neonates:: Systematic comparisons of models from the literature, and development of a new meta-model', European Journal of Pharmaceutical Sciences, v. 92, pp. 117-130. Olsen, B, Foster, DJR, Upton, RN, OA, Ross, JR, DJ, SH, Drewes, AM & Kreilgaard, M 2016, 'Modelling the PKPD of oxycodone in experimental pain - impact of opioid receptor polymorphisms', European Journal of Pharmaceutical Sciences, v. 86, pp. 41 - 49. Wojciechowski, J, Wiese, MD, Proudman, SM, Foster, DJ & Upton, RN 2016, 'A model-based evaluation of single metrics for discriminating changes in rheumatoid arthritis disease activity', British Journal of Clinical Pharmacology, v. 81, no. 6, pp. 1046-1057. Abuhelwa, AY, Foster, DJ, Mudge, S, Hayes, D & Upton, RN 2015, 'Population pharmacokinetic modeling of itraconazole and hydroxyitraconazole for oral suba-itraconazole and sporanox capsule formulations in healthy subjects in fed and fasted states', Antimicrobial Agents and Chemotherapy, v. 59, no. 9, pp. 5681-5696. Abuhelwa, AY, Foster, DJR & Upton, RN 2015, 'ADVAN-style analytical solutions for common pharmacokinetic models', Journal of Pharmacological and Toxicological Methods, v. 73, pp. 42-48. Hopkins, AM, Foster, D, Wiese, M & Upton, R 2015, 'Response to Physiologically Based Pharmacokinetic Model for Prediction of Leflunomide and Teriflunomide - Should Consideration Be Given to Cannalicular Efflux Transporters?', CPT: Pharmacometrics and Systems Pharmacology, v. 4, pp. 464. Hopkins, AM, Wiese, MD, Proudman, SM, O'Doherty, C, Foster, DJR & Upton, RN 2015, 'Semiphysiologically based pharmacokinetic model of leflunomide disposition in rheumatoid arthritis patients', CPT: Pharmacometrics & Systems Pharmacology. Hopkins, AM, Wiese, MD, Proudman, SM, O'Doherty, CE, Upton, RN & Foster, DJR 2015, 'Genetic polymorphism of CYP1A2 but not total or free teriflunomide concentrations is associated with leflunomide cessation in rheumatoid arthritis', British Journal of Clinical Pharmacology, v. 81, no. 1, pp. 113-123. Wojciechowski, J, Wiese, MD, Proudman, SM, Foster, DJR & Upton, RN 2015, 'A Population Model of Early Rheumatoid Arthritis Disease Activity during treatment with Methotrexate, Sulfasalazine and Hydroxychloroquine', British Journal of Clinical Pharmacology, in press. Yata, M, McLachlan, A, Foster, DJR, Page, SW & Beijerink, N 2015, 'Pharmacokinetics and cardiovascular effects following a single oral administration of a nonaqueous pimobendan solution in healthy dogs', Journal of Veterinary Pharmacology and Therapeutics, online. Hopkins, AM, King, CE, Foster, DJR, Suppiah, V, Upton, RN, Spargo, L, Cleland, L, Proudman, SM & Wiese, MD 2014, 'The rheumatoid arthritis susceptibility polymorphism PTPN22 C1858T is not associated with leflunomide response or toxicity', Journal of Clinical Pharmacy and Therapeutics, v. 39, no. 5, pp. 555-560. Hopkins, AM, O'Doherty, CE, Foster, DJR, Upton, RN, Proudman, SM & Wiese, MD 2014, 'Individualization of leflunomide dosing in rheumatoid arthritis patients', Personalized medicine, v. 11, no. 4, pp. 449-461. Juul, R, Foster, DJ, Upton, R, Andresen, T, Graversen, C, Drewes, AM, Christrup, L & Kreilgaard, M 2014, 'Pharmacodynamic Modelling of Placebo and Buprenorphine Effects on Event-Related Potentials in Experimental Pain', Basic and Clinical Pharmacology and Toxicology, v. 115, no. 4 , pp.343-351. Ravn, P, Foster, DJ, Kreilgaard, M, Christrup, L, Werner, MU, Secher, EL, Skram, U & Upton, R 2014, 'Pharmacokinetic-pharmacodynamic modelling of the analgesic and antihyperalgesic effects of morphine after intravenous infusion in human volunteers', Basic and Clinical Pharmacology and Toxicology, v. 115, no. 3, pp. 257-267. Sverrisdottir, E, Foster, DJR, Upton, RN, Olesen, A, Lund, T, Gabel-Jensen, C, Drewes, AM, Christrup, L & Kreilgaard, M 2014, 'Modelling concentration-analgesia relationships for morphine to evaluate experimental pain models', European Journal of Pharmaceutical Sciences, v. 66, pp. 50-58. Lewis, AL, Holden, RR, Chung, ST, Czuczman, P, Kuchel, T, Finnie, J, Porter, S & Foster, D 2013, 'Feasibility, safety and pharmacokinetic study of hepatic administration of drug-eluting beads loaded with irinotecan (DEBIRI) followed by intravenous administration of irinotecan in a porcine model', Journal of Materials Science: Materials in Medicine, v. 24, no. 1, pp. 115-127. Barratt, D, Coller, J, Hallinan, R, Byrne, A, White, JM, Foster, DJR & Somogyi, A 2012, 'ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogenetics', Pharmacogenomics and Personalized Medicine, v. 5, no. 1, pp. 53-62. Upton, RN, Foster, DJR, Christrup, L, Dale, O, Moksnes, K & Popper, L 2012, 'A physiologically-based recirculatory meta-model for nasal fentanyl in man', Journal of Pharmacokinetics and Pharmacodynamics, v. 39, no. 5, pp. 561-576.